Adiposogenital dystrophy pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
==Overview==
==Overview==
The pathogenesis of adiposogenital dystrophy is believed to result from damage to the hypothalamus which links the nervous system to the endocrine system through the pituitary gland.  
The pathogenesis of adiposogenital dystrophy is believed to result from damage to the [[hypothalamus]] which links the [[nervous system]] to the [[endocrine system]] through the pituitary gland.  
==Pathophysiology==
==Pathophysiology==
The pathogenesis of adiposogenital dystrophy is believed to result from damage to the hypothalamus (arcuate nucleus and ventromedial nuclei) which links the nervous system to the endocrine system through the pituitary gland.{{cite web |url=https://rarediseases.org/rare-diseases/froelichs-syndrome/ |title=Froelich Syndrome - NORD (National Organization for Rare Disorders) |format= |work= |accessdate=}}  
The pathogenesis of adiposogenital dystrophy is believed to result from damage to the [[hypothalamus]] (arcuate nucleus and ventromedial nuclei) which links the [[nervous system]] to the [[endocrine system]] through the pituitary gland.{{cite web |url=https://rarediseases.org/rare-diseases/froelichs-syndrome/ |title=Froelich Syndrome - NORD (National Organization for Rare Disorders) |format= |work= |accessdate=}}  
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 01:16, 18 August 2021

Adiposogenital dystrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adiposogenital dystrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Head X Ray

CT

MRI

Vision Test

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adiposogenital dystrophy pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adiposogenital dystrophy pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adiposogenital dystrophy pathophysiology

CDC on Adiposogenital dystrophy pathophysiology

Adiposogenital dystrophy pathophysiology in the news

Blogs on Adiposogenital dystrophy pathophysiology

Directions to Hospitals Treating Adiposogenital dystrophy

Risk calculators and risk factors for Adiposogenital dystrophy pathophysiology

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

The pathogenesis of adiposogenital dystrophy is believed to result from damage to the hypothalamus which links the nervous system to the endocrine system through the pituitary gland.

Pathophysiology

The pathogenesis of adiposogenital dystrophy is believed to result from damage to the hypothalamus (arcuate nucleus and ventromedial nuclei) which links the nervous system to the endocrine system through the pituitary gland."Froelich Syndrome - NORD (National Organization for Rare Disorders)".

References

Template:WH Template:WS